The invention of vaccines is one of humanity's greatest public health achievements and the most cost-effective and effective means of preventing and controlling infectious diseases. Especially since the outbreak of the COVID-19 pandemic, there has been an increasing focus from all sectors of society on the vaccine industry. During the COVID-19 pandemic, vaccines based on various technical approaches have been applied in actual epidemic prevention, among which the successful development of new technology-based vaccines represented by nucleic acid vaccines has brought about significant changes to the vaccine industry.
Frost & Sullivan (Frost & Sullivan, abbreviated as 'Frost & Sullivan') officially released the 'Research Report on the Current Development and Future Trends of the Human Vaccination Market' (hereinafter referred to as the 'Report') on February 8, 2023. The report conducts an in-depth analysis of the global and Chinese vaccine industries, exploring the huge unmet needs in the vaccine field from multiple aspects such as patient demand, treatment status quo, technological development, market growth, capital interest, and industry structure. It tracks the context of industry and technological development and analyzes the driving factors behind market development.
